XML 84 R70.htm IDEA: XBRL DOCUMENT v3.25.0.1
License Agreements - Harvard License Agreement - Additional Information (Details) - Harvard
 12 Months Ended
Jun. 10, 2021
shares
Dec. 31, 2024
USD ($)
May 31, 2021
USD ($)
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Success payment amount due     $ 15,000,000
Common Stock      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Issuance of common stock for success payment liability, Shares | shares 174,825    
Minimum      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Success payments   $ 5,000,000  
Minimum | Series A Preferred Stock      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Success Payments, valuation multiples   5  
Maximum      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Additional success payment amount due   $ 90,000,000  
Success payments   $ 105,000,000  
Maximum | Series A Preferred Stock      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Success Payments, valuation multiples   40  
Success Payments      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Agreement description   The Company is required to make success payments to Harvard during a period of time, or the Harvard Success Payment Period, which has been determined to be the later of (1) the ninth anniversary of the Harvard License Agreement or (2) the earlier of (a) the twelfth anniversary of the Harvard License Agreement and (b) the third anniversary of the first date on which a licensed product receives regulatory approval in the United States. During the Harvard Success Payment Period, the Company will perform a calculation of any amounts owed to Harvard on each rolling 90-day period, commencing one year after the Company’s IPO.  
Other Payments      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Agreement description   The Company agreed to pay Harvard an annual license maintenance fee ranging from low-to-mid five figures to low six figures, depending on the calendar year. The Company is responsible for the payment of certain patent prosecution and maintenance costs incurred by Harvard related to licensed patents. To the extent achieved, the Company is obligated to pay up to an aggregate of $75.9 million in product development and regulatory approval milestones, or Harvard Product Milestones. If the Company completes a change of control during the term of the Harvard License Agreement, then certain of the milestone payments would be increased. To the extent there are sales of a licensed product, the Company is required to pay low single digit royalties on net sales. The Company is entitled to certain reductions and offsets on these royalties with respect to a licensed product in a given country. If the Company sublicenses its rights to develop or commercialize a licensed product under the Harvard License Agreement to a third party and the Company receives non-royalty sublicense income, then Harvard is entitled to a percentage of such consideration, ranging from the high single digits to low double digits depending on the date in which such sublicense agreement is executed and the stage of development of the Company’s licensed products at such time.  
Product Development and Regulatory Approval | Maximum      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]      
Aggregate milestone amount   $ 75,900,000